Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry

View source ↗

Summary

The GI-FLX Registry evaluating left atrial appendage closure with the WATCHMAN FLX device in patients with atrial fibrillation and recurrent gastrointestinal bl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WATCHMAN FLX

Snippet

Sponsor: Kansas City Heart Rhythm Research Foundation | Conditions: Atrial Fibrillation, GI Bleeding | Status: TERMINATED